Scientific Program

Scientific Program

Diverse formats of Scientific Program

Preconference Workshops

2 Masterclass workshops will be held Sunday, 10 Nov. Prior registration is required as seats are limited to 50 pax each

Option 1 : Genetics and Genomics

We will cover the advances & potential impact  of Genetics and Genomics on the Life and Health insurance industry

  • General concepts and background

  • Key technological breakthroughs (Liquid Biopsies, SNPs, Whole Genome Sequencing, CRISPR)

  • Types of genetic testing – where, why and when are they used?

  • General view of regulation and restrictions by various jurisdictions

  • Genome Editing / Precision Medicine – Quo Vadis?

  • Case Scenarios / Discussions

Option 2 : Histopathology interpretation made easy: Every detail matters​

Underwriting an applicant with cancer or assessment of CI claim of cancer requires up-to-date insight about the microscopic features of the underlying condition. In our day to day work, we seldom get a chance to brush upon our knowledge regarding the interpretation of Histopathology Reports. 

Additionally, modern day histopathology has evolved beyond cellular morphology to include markers that can be detected using antibody tests (Immunophenotype ) or their enzymes that enable certain reactions (cytochemistry ) and their chromosomal changes (Karyotype). In insurance there is a need to keep pace with these changes as they are ultimately linked to prognosis of the underlying condition. 

This interactive workshop is aimed at offering a bird's-eye view on histopathology, starting with basics to a comprehensive updated review of few cancers followed by relevant case studies.

We have on board experienced pathologists to guide us through the nuances of this topic and to make Histopathology Interpretation Easy! 

Concurrent Sessions

As part of the scientific program, Concurrent sessions with specialized themes like Cancer, Diabetes, Cardiovascular Diseases will be conducted to provide practical solutions to technical topics

Technology Session

ICLAM Mumbai 2019 and The Digital Insurer are collaborating to deliver concurrent sessions on how InsurTech is changing the medical, underwriting and claims disciplines in the insurance industry.Each session will follow a fast-paced panel format where panellists deliver short mini-presentations allowing time to leverage the collective experience of both the panellists and audience in the room in an open floor Q&A that will explore:

  • How traditional medical services have been/are being redefined by technology

  • How the acquisition process is being improved through digital-first approaches and technology

  • How claims processes are being disrupted with greater focus on prevention, alongside processes that increase efficiency and management of fraud, waste and abuse

Satellite Sessions

The satellite programme will be provided by the where expert speakers from our main sponsors will address the "translation" of theory into practice. Topics like Mental Health, Disability and Health insurance will be covered.


Al Klein, Principal and Consulting Actuary, Milliman USA, Long Term Drivers of Mortality and Morbidit

Dr Eric Raymond, Head of Medical Oncology at Paris Saint-Joseph Hospital Group

Mr. Maneul Plisson, Head of UW & Claims R&D Centre, SCOR Global Life

Cure for cancer: how far are we and how would it change insurance?

Ronald Klein, Director, Global Ageing, Geneva Association , Genetic Regulations vs Direct to Consumer Genetics Test - What does the future hold?“

Dr Kumar Prabash, Senior Medical Oncologist, Tata Memorial Hospital, Clinical Medicine
An Insiders’ view on Liquid Biopsy and Immunotherapy: Hype or Hope for the next decade

Prof Matthieu Allez, Hopital Saint-Louis, Paris, Dpt. Gastroenterology & Hepatology,
Looking into Future of IBD (Inflammatory Bowel Disease)

Dr Andreas Armuss, Chief Medical Officer (Asia Pacific, Middle East and Africa), Munich Re,
Advances in Cancer Diagnosis and Treatment :What does all mean for Underwriting and Claims (CI/DI)?

Prof. Takesumi Yoshimura, Director, Emergency Life-Saving Technique Academy of Kyushu,
Radiation and its impact on Cancer- What we can learn from Japan about the long term impact of cosmic ray and radiation exposure on cancer?

Dr Yash Lokhandwala, Cardiologist and Electrophysiologist,
Risk Stratifying Asymptomatic Arrythmias

Dr Paul Davis, Chief Medical Officer,RGA Australia, Coronary CT angiography- clinical reporting vs insurance interpretation

Lawerence Tsui, Director of Life & Health Products, Swiss Re Cancer Only Product experience around the globe !

Dr John O’brien, Life/Health Chief Medical Officer, London, Sweetening the deal- Products for Diabetics and its experience

  Many more presentations


Sunday 10 Nov 2019

10:00 – 16:00

ICLAM Board & Bureau meetings

Invitation only

12:00 – 16:30

Pre-conference Workshops

Public, to be purchased separately

18:00 – 20:00

Welcome Reception

Delegates & accompanying guest

Monday 11 Nov 2019

08:30 – 09:00

Opening ceremony


09:00 – 17:00

Scientific programme


09:00 – 17:00

Full Day Tour

Accompanying guests

Tuesday 12 Nov 2019

08:30 – 17:00

Scientific programme


09:30 – 14:30

Accompanying guests Tours

Accompanying guests, to be purchased separately

19:00 – 23:00

Gala Dinner

Delegates & accompanying guests

Wednesday 13 Nov 2019

08:30 – 11:00

Scientific programme


09:30 – 11:30

ICLAM 2019, Closing ceremony

Delegates & accompanying guests

12:00 – 18:00

City tour

Delegates registered for tour & accompanying guests

Back to top